Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
No treatment has surpassed platinum-based chemotherapy in improving overall survival in patients with previously untreated locally advanced or metastatic urothelial carcinoma. We conducted a phase 3, global, open-label, randomized trial to compare the …